Allogeneic anti-PSMA CAR-NK cell

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic anti-PSMA CAR-NK cell, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer [EARLY_Phase 1]